Artelo Biosciences (ARTL) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sunshine Biopharma is the larger company by market cap ($1.9 million vs $1.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ARTL | SBFM |
|---|---|---|
| Share price | $3.37 | $0.43 |
| Market cap | $1.85M | $1.85M |
| 1-day change | -1.17% | -38.57% |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $-136.26 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $179.19 | $24.30 |
| 52-week low | $3.33 | $0.356 |
| Distance from 52-week high | -98.12% | -98.23% |
| Average volume | 480.72K | 3.33M |
| Shares outstanding | 547.77K | 4.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARTL vs SBFM FAQ
Which is bigger, Artelo Biosciences or Sunshine Biopharma?
Sunshine Biopharma (SBFM) is larger, with a market capitalization of $1.85M compared with $1.85M for Artelo Biosciences (ARTL).
Are Artelo Biosciences and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.